Mobileye heads into its third-quarter report with an awkward split between what management has been saying and what the market has been doing. The company has raised its full-year revenue outlook on three straight calls, yet the stock has slid about 10% since the last report while the S&P 500 gained 4%. That gap frames the October 29 release, due before the open: investors seem to doubt that the improving core story can outlast a weaker second half, a costly Robotaxi push and a leadership change.
The quarter itself is not expected to look good on the surface. Consensus calls for revenue of $473.8 million, about 6% below the year-ago $504 million and well under the $508 million posted last quarter. That is no surprise, because management guided Q3 revenue down roughly 5% to 6% year over year, so the Street is simply following the company's lead. Non-GAAP EPS is expected at $0.10, matching last quarter and far above the year-ago penny. The Earnings Whisper is also $0.10, which suggests the informal bar sits right at consensus rather than above it. Most of that profit improvement comes from the new Israeli R&D incentive, which management expects to provide $180 million to $200 million of contra-R&D benefit this year and describes as ongoing. It is real money, but it is tax policy rather than operating leverage, and it was flagged as lumpy from quarter to quarter.
The full-year guidance matters more than the quarterly line. Management now expects 2026 revenue of $1.97 billion to $2.02 billion, while consensus of $1.98 billion sits in the lower half of that range. Analysts have not fully accepted the latest raise, and the reason is clear. A soft Q3 leaves a heavier load on the fourth quarter. If Mobileye reaffirms or narrows the range toward the midpoint while delivering Q3 as guided, it would imply a solid year-end ramp and support the case that its outperformance against weak customer production is lasting. A trim toward the low end would undercut the main point of the last call.
The specific swing factors came straight from that call. Supervision shipments were held at just under 60,000 units for the year despite a strong first half, because customers had taken roughly 40,000 units against about 30,000 of end demand and need to work through inventory. Investors should look for evidence that this drawdown is on schedule rather than spreading into 2027. Average selling price is the second test. Last quarter's ASP slipped on a heavier mix of lower-priced volume from Chinese OEM exports, and another decline would show that volume gains are coming at the cost of pricing. Updates on the Stellantis cloud-enhanced ADAS program, which management said carries about twice the gross profit per unit of base ADAS, would help offset worries that some automakers are testing multi-supplier setups.
Then there is the strategic overhang. The move to build a fully vertically integrated Robotaxi service for a 2027 U.S. launch brings new opex and capex, and the market will want early detail on spending pace, Moya testing in Hamburg, and the unit economics management has promised, including about $125,000 of annual revenue per vehicle. Any progress on finding a successor to CEO Amnon Shashua would also reduce uncertainty.
Sentiment has turned from mildly bullish before the last report to clearly bearish now, and the stock at $7.30 sits well under its 200-day average of $8.73 and near the bottom of its post-earnings range. That lowers the bar somewhat but does not remove it. The central question is whether Mobileye can show that its core ADAS momentum, rather than a tax credit, is carrying the year, while keeping Robotaxi spending from overwhelming that story.